[
    {
        "pk": 8, 
        "model": "Interaction.gene", 
        "fields": {
            "Entrez": 155971, 
            "Organism": "HIV", 
            "Name": "Envelope transmembrane glycoprotein gp41", 
            "ExtraNames": [
                7172, 
                7175
            ]
        }
    }, 
    {
        "pk": 4, 
        "model": "Interaction.mutationtags", 
        "fields": {
            "Slug": "viral-rebound", 
            "Description": ""
        }
    }, 
    {
        "pk": 1180, 
        "model": "Interaction.mutation", 
        "fields": {
            "Mut": "A50V", 
            "Gene": 8, 
            "Position": 50
        }
    }, 
    {
        "pk": 11520, 
        "model": "Interaction.article", 
        "fields": {
            "Title": null, 
            "PMCXML": null, 
            "Interactions": [], 
            "PubMedXML": "<pubmedarticle>\n<medlinecitation owner=\"NLM\" status=\"MEDLINE\">\n <pmid>\n  16927284\n </pmid>\n <datecreated>\n  <year>\n   2006\n  </year>\n  <month>\n   08\n  </month>\n  <day>\n   28\n  </day>\n </datecreated>\n <datecompleted>\n  <year>\n   2006\n  </year>\n  <month>\n   10\n  </month>\n  <day>\n   13\n  </day>\n </datecompleted>\n <daterevised>\n  <year>\n   2006\n  </year>\n  <month>\n   11\n  </month>\n  <day>\n   15\n  </day>\n </daterevised>\n <article pubmodel=\"Print\">\n  <journal>\n   <issn issntype=\"Print\">\n    0146-6615\n   </issn>\n   <journalissue citedmedium=\"Print\">\n    <volume>\n     78\n    </volume>\n    <issue>\n     10\n    </issue>\n    <pubdate>\n     <year>\n      2006\n     </year>\n     <month>\n      Oct\n     </month>\n    </pubdate>\n   </journalissue>\n   <title>\n    Journal of medical virology\n   </title>\n   <isoabbreviation>\n    J. Med. Virol.\n   </isoabbreviation>\n  </journal>\n  <articletitle>\n   A cohort study of enfuvirtide immunological and virological efficacy in clinical practice.\n  </articletitle>\n  <pagination>\n   <medlinepgn>\n    1312-7\n   </medlinepgn>\n  </pagination>\n  <abstract>\n   <abstracttext>\n    The aim of the study was to evaluate, under routine circumstances, the immunological and virological efficacy of antiretroviral regimens containing enfuvirtide in multi-class experienced HIV-1 infected patients. This retrospective monocentric study analyzed the clinical, immunological, and virological data of 18 HIV-1 infected patients who started enfuvirtide and completed at least 3 months of therapy. Following 3 months of enfuvirtide therapy, 11 (61%) patients had HIV-1 RNA below 400 copies/ml, among whom 8 (44%) patients below 50 copies/ml. In the ten patients still receiving enfuvirtide after 12 months, the median increase in CD4 cell count was 159 cells/microl (range, -25 to +301) and the mean decrease in HIV-1 RNA was 2.5 +/- 1.4 log(10) copies/ml; in six of these patients, viral load remained below 50 copies/ml. Five patients discontinued enfuvirtide for virological failure but none as a consequence of adverse event. Mutations located within the 36-45 amino acid domain of HR1 region of gp41 and associated to enfuvirtide resistance were found in all seven patients with persistent viral replication. In addition, a new mutation, A50V, emerged in one patient with late viral rebound. Its disappearance after treatment discontinuation suggests that it could play a role in resistance to enfuvirtide. In conclusion, enfuvirtide may be a good therapeutic option as rescue therapy in treatment-experienced patients. However, the mutations conferring resistance to enfuvirtide develop rapidly when viral load is not controlled confirming that enfuvirtide should be prescribed in association with an active background regimen.\n   </abstracttext>\n  </abstract>\n  <affiliation>\n   Universit Paris Descartes, Facult de mdecine, Paris, France.\n  </affiliation>\n  <authorlist completeyn=\"Y\">\n   <author validyn=\"Y\">\n    <lastname>\n     Bienvenu\n    </lastname>\n    <forename>\n     Boris\n    </forename>\n    <initials>\n     B\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Krivine\n    </lastname>\n    <forename>\n     Anne\n    </forename>\n    <initials>\n     A\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Rollot\n    </lastname>\n    <forename>\n     Florence\n    </forename>\n    <initials>\n     F\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Pietri\n    </lastname>\n    <forename>\n     Marie-Pierre\n    </forename>\n    <initials>\n     MP\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Lebault\n    </lastname>\n    <forename>\n     Valrie\n    </forename>\n    <initials>\n     V\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Meritet\n    </lastname>\n    <forename>\n     Jean-Franois\n    </forename>\n    <initials>\n     JF\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Guerin\n    </lastname>\n    <forename>\n     Corinne\n    </forename>\n    <initials>\n     C\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Spiridon\n    </lastname>\n    <forename>\n     Gabriela\n    </forename>\n    <initials>\n     G\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Salmon\n    </lastname>\n    <forename>\n     Dominique\n    </forename>\n    <initials>\n     D\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Guillevin\n    </lastname>\n    <forename>\n     Loc\n    </forename>\n    <initials>\n     L\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Lebon\n    </lastname>\n    <forename>\n     Pierre\n    </forename>\n    <initials>\n     P\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Launay\n    </lastname>\n    <forename>\n     Odile\n    </forename>\n    <initials>\n     O\n    </initials>\n   </author>\n  </authorlist>\n  <language>\n   eng\n  </language>\n  <publicationtypelist>\n   <publicationtype>\n    Journal Article\n   </publicationtype>\n   <publicationtype>\n    Research Support, Non-U.S. Gov't\n   </publicationtype>\n  </publicationtypelist>\n </article>\n <medlinejournalinfo>\n  <country>\n   United States\n  </country>\n  <medlineta>\n   J Med Virol\n  </medlineta>\n  <nlmuniqueid>\n   7705876\n  </nlmuniqueid>\n  <issnlinking>\n   0146-6615\n  </issnlinking>\n </medlinejournalinfo>\n <chemicallist>\n  <chemical>\n   <registrynumber>\n    0\n   </registrynumber>\n   <nameofsubstance>\n    HIV Envelope Protein gp41\n   </nameofsubstance>\n  </chemical>\n  <chemical>\n   <registrynumber>\n    0\n   </registrynumber>\n   <nameofsubstance>\n    HIV Fusion Inhibitors\n   </nameofsubstance>\n  </chemical>\n  <chemical>\n   <registrynumber>\n    0\n   </registrynumber>\n   <nameofsubstance>\n    Peptide Fragments\n   </nameofsubstance>\n  </chemical>\n  <chemical>\n   <registrynumber>\n    0\n   </registrynumber>\n   <nameofsubstance>\n    RNA, Viral\n   </nameofsubstance>\n  </chemical>\n  <chemical>\n   <registrynumber>\n    0\n   </registrynumber>\n   <nameofsubstance>\n    enfuvirtide\n   </nameofsubstance>\n  </chemical>\n </chemicallist>\n <citationsubset>\n  IM\n </citationsubset>\n <meshheadinglist>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Adult\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Aged\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    CD4 Lymphocyte Count\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Cohort Studies\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Drug Resistance, Viral\n   </descriptorname>\n   <qualifiername majortopicyn=\"N\">\n    genetics\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Female\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    HIV Envelope Protein gp41\n   </descriptorname>\n   <qualifiername majortopicyn=\"N\">\n    genetics\n   </qualifiername>\n   <qualifiername majortopicyn=\"N\">\n    pharmacology\n   </qualifiername>\n   <qualifiername majortopicyn=\"Y\">\n    therapeutic use\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    HIV Fusion Inhibitors\n   </descriptorname>\n   <qualifiername majortopicyn=\"N\">\n    pharmacology\n   </qualifiername>\n   <qualifiername majortopicyn=\"Y\">\n    therapeutic use\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    HIV Infections\n   </descriptorname>\n   <qualifiername majortopicyn=\"Y\">\n    drug therapy\n   </qualifiername>\n   <qualifiername majortopicyn=\"N\">\n    immunology\n   </qualifiername>\n   <qualifiername majortopicyn=\"N\">\n    virology\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    HIV-1\n   </descriptorname>\n   <qualifiername majortopicyn=\"N\">\n    drug effects\n   </qualifiername>\n   <qualifiername majortopicyn=\"N\">\n    genetics\n   </qualifiername>\n   <qualifiername majortopicyn=\"Y\">\n    isolation &amp; purification\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Hospitals, Teaching\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Humans\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Male\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Middle Aged\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Mutation\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Peptide Fragments\n   </descriptorname>\n   <qualifiername majortopicyn=\"N\">\n    pharmacology\n   </qualifiername>\n   <qualifiername majortopicyn=\"Y\">\n    therapeutic use\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Protein Structure, Tertiary\n   </descriptorname>\n   <qualifiername majortopicyn=\"N\">\n    genetics\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    RNA, Viral\n   </descriptorname>\n   <qualifiername majortopicyn=\"N\">\n    blood\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Retrospective Studies\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Salvage Therapy\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Treatment Outcome\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Viral Load\n   </descriptorname>\n  </meshheading>\n </meshheadinglist>\n</medlinecitation>\n<pubmeddata>\n <history>\n  <pubmedpubdate pubstatus=\"pubmed\">\n   <year>\n    2006\n   </year>\n   <month>\n    8\n   </month>\n   <day>\n    24\n   </day>\n   <hour>\n    9\n   </hour>\n   <minute>\n    0\n   </minute>\n  </pubmedpubdate>\n  <pubmedpubdate pubstatus=\"medline\">\n   <year>\n    2006\n   </year>\n   <month>\n    10\n   </month>\n   <day>\n    14\n   </day>\n   <hour>\n    9\n   </hour>\n   <minute>\n    0\n   </minute>\n  </pubmedpubdate>\n  <pubmedpubdate pubstatus=\"entrez\">\n   <year>\n    2006\n   </year>\n   <month>\n    8\n   </month>\n   <day>\n    24\n   </day>\n   <hour>\n    9\n   </hour>\n   <minute>\n    0\n   </minute>\n  </pubmedpubdate>\n </history>\n <publicationstatus>\n  ppublish\n </publicationstatus>\n <articleidlist>\n  <articleid idtype=\"doi\">\n   10.1002/jmv.20700\n  </articleid>\n  <articleid idtype=\"pubmed\">\n   16927284\n  </articleid>\n </articleidlist>\n</pubmeddata>\n</pubmedarticle>\n", 
            "PMID": 16927284, 
            "HasMut": false, 
            "PMCID": null
        }
    }, 
    {
        "pk": 3, 
        "model": "Interaction.mutationtags", 
        "fields": {
            "Slug": "lower-infection-rate", 
            "Description": ""
        }
    }, 
    {
        "pk": 1177, 
        "model": "Interaction.mutation", 
        "fields": {
            "Mut": "W61D", 
            "Gene": 8, 
            "Position": 61
        }
    }, 
    {
        "pk": 15716, 
        "model": "Interaction.article", 
        "fields": {
            "Title": null, 
            "PMCXML": null, 
            "Interactions": [], 
            "PubMedXML": "<pubmedarticle>\n<medlinecitation owner=\"NLM\" status=\"MEDLINE\">\n <pmid>\n  9519819\n </pmid>\n <datecreated>\n  <year>\n   1998\n  </year>\n  <month>\n   04\n  </month>\n  <day>\n   23\n  </day>\n </datecreated>\n <datecompleted>\n  <year>\n   1998\n  </year>\n  <month>\n   04\n  </month>\n  <day>\n   23\n  </day>\n </datecompleted>\n <daterevised>\n  <year>\n   2006\n  </year>\n  <month>\n   11\n  </month>\n  <day>\n   15\n  </day>\n </daterevised>\n <article pubmodel=\"Print\">\n  <journal>\n   <issn issntype=\"Print\">\n    0022-1317\n   </issn>\n   <journalissue citedmedium=\"Print\">\n    <volume>\n     79 ( Pt 3)\n    </volume>\n    <pubdate>\n     <year>\n      1998\n     </year>\n     <month>\n      Mar\n     </month>\n    </pubdate>\n   </journalissue>\n   <title>\n    The Journal of general virology\n   </title>\n   <isoabbreviation>\n    J. Gen. Virol.\n   </isoabbreviation>\n  </journal>\n  <articletitle>\n   Evaluation of a candidate human immunodeficiency virus type 1 (HIV-1) vaccine in macaques: effect of vaccination with HIV-1 gp120 on subsequent challenge with heterologous simian immunodeficiency virus-HIV-1 chimeric virus.\n  </articletitle>\n  <pagination>\n   <medlinepgn>\n    423-32\n   </medlinepgn>\n  </pagination>\n  <abstract>\n   <abstracttext>\n    Human immunodeficiency virus type 1 (HIV-1) envelope vaccines can now be evaluated for efficacy in macaques by challenging with chimeric viruses in which the env, tat and rev genes of simian immunodeficiency virus (SIV) have been replaced by those of HIV-1. Most experiments have so far been conducted using gp120 molecules derived from T-cell-adapted LAI or MN strains of HIV-1, which predominantly use the CXCR-4 co-receptor. These vaccines protect against infection by apathogenic chimeric virus carrying the same envelope sequences. In the experiment described here, four macaques were vaccinated with W61D gp120 derived from a low passage Dutch isolate and capable of inhibiting the binding of MIP1beta to the co-receptor CCR-5. This vaccine was potent, inducing high titres of binding and neutralizing antibodies against the homologous HIV-1 and tenfold lower titres against a heterologous challenge virus (SHIV(SF33)) in which the env, tat and rev genes of SIV had been replaced by those of a San Francisco isolate, HIV-1(SF33). Despite strong immune responses to the vaccine there was no evidence that it protected against challenge with this chimeric virus. The antigenic divergence between vaccine and challenge virus or the increased virulence of the challenge virus may be responsible for the inability of this vaccine to protect against infection by SHIV(SF33).\n   </abstracttext>\n  </abstract>\n  <affiliation>\n   Division of Retrovirology, National Institute for Biological Standards &amp; Control, Potters Bar, Herts, UK. jstott@nibsc.ac.uk\n  </affiliation>\n  <authorlist completeyn=\"Y\">\n   <author validyn=\"Y\">\n    <lastname>\n     Stott\n    </lastname>\n    <forename>\n     E J\n    </forename>\n    <initials>\n     EJ\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Almond\n    </lastname>\n    <forename>\n     N\n    </forename>\n    <initials>\n     N\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Kent\n    </lastname>\n    <forename>\n     K\n    </forename>\n    <initials>\n     K\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Walker\n    </lastname>\n    <forename>\n     B\n    </forename>\n    <initials>\n     B\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Hull\n    </lastname>\n    <forename>\n     R\n    </forename>\n    <initials>\n     R\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Rose\n    </lastname>\n    <forename>\n     J\n    </forename>\n    <initials>\n     J\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Silvera\n    </lastname>\n    <forename>\n     P\n    </forename>\n    <initials>\n     P\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Sangster\n    </lastname>\n    <forename>\n     R\n    </forename>\n    <initials>\n     R\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Corcoran\n    </lastname>\n    <forename>\n     T\n    </forename>\n    <initials>\n     T\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Lines\n    </lastname>\n    <forename>\n     J\n    </forename>\n    <initials>\n     J\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Silvera\n    </lastname>\n    <forename>\n     K\n    </forename>\n    <initials>\n     K\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Luciw\n    </lastname>\n    <forename>\n     P\n    </forename>\n    <initials>\n     P\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Murphy-Corb\n    </lastname>\n    <forename>\n     M\n    </forename>\n    <initials>\n     M\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Momin\n    </lastname>\n    <forename>\n     P\n    </forename>\n    <initials>\n     P\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Bruck\n    </lastname>\n    <forename>\n     C\n    </forename>\n    <initials>\n     C\n    </initials>\n   </author>\n  </authorlist>\n  <language>\n   eng\n  </language>\n  <publicationtypelist>\n   <publicationtype>\n    Journal Article\n   </publicationtype>\n   <publicationtype>\n    Research Support, Non-U.S. Gov't\n   </publicationtype>\n  </publicationtypelist>\n </article>\n <medlinejournalinfo>\n  <country>\n   ENGLAND\n  </country>\n  <medlineta>\n   J Gen Virol\n  </medlineta>\n  <nlmuniqueid>\n   0077340\n  </nlmuniqueid>\n  <issnlinking>\n   0022-1317\n  </issnlinking>\n </medlinejournalinfo>\n <chemicallist>\n  <chemical>\n   <registrynumber>\n    0\n   </registrynumber>\n   <nameofsubstance>\n    AIDS Vaccines\n   </nameofsubstance>\n  </chemical>\n  <chemical>\n   <registrynumber>\n    0\n   </registrynumber>\n   <nameofsubstance>\n    Antibodies, Viral\n   </nameofsubstance>\n  </chemical>\n  <chemical>\n   <registrynumber>\n    0\n   </registrynumber>\n   <nameofsubstance>\n    HIV Envelope Protein gp120\n   </nameofsubstance>\n  </chemical>\n  <chemical>\n   <registrynumber>\n    0\n   </registrynumber>\n   <nameofsubstance>\n    Recombinant Fusion Proteins\n   </nameofsubstance>\n  </chemical>\n </chemicallist>\n <citationsubset>\n  IM\n </citationsubset>\n <citationsubset>\n  X\n </citationsubset>\n <meshheadinglist>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    AIDS Vaccines\n   </descriptorname>\n   <qualifiername majortopicyn=\"Y\">\n    immunology\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Animals\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Antibodies, Viral\n   </descriptorname>\n   <qualifiername majortopicyn=\"Y\">\n    biosynthesis\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Enzyme-Linked Immunosorbent Assay\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    HIV Envelope Protein gp120\n   </descriptorname>\n   <qualifiername majortopicyn=\"Y\">\n    immunology\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    HIV Infections\n   </descriptorname>\n   <qualifiername majortopicyn=\"Y\">\n    prevention &amp; control\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    HIV-1\n   </descriptorname>\n   <qualifiername majortopicyn=\"N\">\n    genetics\n   </qualifiername>\n   <qualifiername majortopicyn=\"Y\">\n    immunology\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Lymphocyte Activation\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Macaca\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Reassortant Viruses\n   </descriptorname>\n   <qualifiername majortopicyn=\"N\">\n    immunology\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Recombinant Fusion Proteins\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Simian immunodeficiency virus\n   </descriptorname>\n   <qualifiername majortopicyn=\"N\">\n    genetics\n   </qualifiername>\n   <qualifiername majortopicyn=\"Y\">\n    immunology\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Time Factors\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Viral Load\n   </descriptorname>\n  </meshheading>\n </meshheadinglist>\n</medlinecitation>\n<pubmeddata>\n <history>\n  <pubmedpubdate pubstatus=\"pubmed\">\n   <year>\n    1998\n   </year>\n   <month>\n    3\n   </month>\n   <day>\n    31\n   </day>\n  </pubmedpubdate>\n  <pubmedpubdate pubstatus=\"medline\">\n   <year>\n    1998\n   </year>\n   <month>\n    3\n   </month>\n   <day>\n    31\n   </day>\n   <hour>\n    0\n   </hour>\n   <minute>\n    1\n   </minute>\n  </pubmedpubdate>\n  <pubmedpubdate pubstatus=\"entrez\">\n   <year>\n    1998\n   </year>\n   <month>\n    3\n   </month>\n   <day>\n    31\n   </day>\n   <hour>\n    0\n   </hour>\n   <minute>\n    0\n   </minute>\n  </pubmedpubdate>\n </history>\n <publicationstatus>\n  ppublish\n </publicationstatus>\n <articleidlist>\n  <articleid idtype=\"pubmed\">\n   9519819\n  </articleid>\n </articleidlist>\n</pubmeddata>\n</pubmedarticle>\n", 
            "PMID": 9519819, 
            "HasMut": false, 
            "PMCID": null
        }
    }, 
    {
        "pk": 12, 
        "model": "Interaction.mutationtags", 
        "fields": {
            "Slug": "efv-resistance", 
            "Description": ""
        }
    }, 
    {
        "pk": 1, 
        "model": "Interaction.mutationtags", 
        "fields": {
            "Slug": "resistance-mutation", 
            "Description": ""
        }
    }, 
    {
        "pk": 1055, 
        "model": "Interaction.mutation", 
        "fields": {
            "Mut": "Q39H", 
            "Gene": 8, 
            "Position": 39
        }
    }, 
    {
        "pk": 10277, 
        "model": "Interaction.article", 
        "fields": {
            "Title": null, 
            "PMCXML": null, 
            "Interactions": [], 
            "PubMedXML": "<pubmedarticle>\n<medlinecitation owner=\"NLM\" status=\"MEDLINE\">\n <pmid>\n  19239358\n </pmid>\n <datecreated>\n  <year>\n   2009\n  </year>\n  <month>\n   02\n  </month>\n  <day>\n   25\n  </day>\n </datecreated>\n <datecompleted>\n  <year>\n   2009\n  </year>\n  <month>\n   03\n  </month>\n  <day>\n   12\n  </day>\n </datecompleted>\n <article pubmodel=\"Print\">\n  <journal>\n   <issn issntype=\"Electronic\">\n    1931-8405\n   </issn>\n   <journalissue citedmedium=\"Internet\">\n    <volume>\n     25\n    </volume>\n    <issue>\n     2\n    </issue>\n    <pubdate>\n     <year>\n      2009\n     </year>\n     <month>\n      Feb\n     </month>\n    </pubdate>\n   </journalissue>\n   <title>\n    AIDS research and human retroviruses\n   </title>\n   <isoabbreviation>\n    AIDS Res. Hum. Retroviruses\n   </isoabbreviation>\n  </journal>\n  <articletitle>\n   Enfuvirtide (T-20) resistance-related mutations in HIV type 1 subtypes B, C, and F isolates from Brazilian patients failing HAART.\n  </articletitle>\n  <pagination>\n   <medlinepgn>\n    193-8\n   </medlinepgn>\n  </pagination>\n  <abstract>\n   <abstracttext>\n    The synthetic peptide T-20 (enfuvirtide, EFV) represents the first compound approved by the FDA known as entry inhibitors (EIs). The resistance mutations associated with this new class of antiretroviral drug are located in the first heptad repeat (HR1) region of gp41. Amino acid changes in codons G36D/S, I37V, V38A/M/E, Q39H/R, Q40H, N42T, and N43D can confer resistance to EFV. In this work we investigated the presence of resistance mutations that occur in patients never treated with EFV and failing HAART with protease inhibitors (PIs), nucleoside reverse transcriptase (RT) inhibitors (NRTIs), and nonnucleoside RT inhibitors (NNRTIs). This knowledge can reveal whether this salvage therapy can be effective in patients failing HAART. For this, we amplified 65 samples from plasma isolates and than sequenced a fragment of 416 nt encompassing the HR1 and HR2 regions (amino acids 33-170 of gp41). The subtype distribution among the 65 isolates was 45 (69.23%) subtype B, 9 (13.85%) subtype C, 7 (10.77%) subtype F1, and 4 (6.15%) mosaics B/F1, B/C, F1/C, and C/F1/B. We found a high prevalence (7.6%) of EFV-associated mutation G36D in this cohort of patients failing HAART therapy, five isolates from subtype B (11.11% within this group). In contrast, when 1079 sequences from drug-naive patients were analyzed, only one showed the G36D substitution. This finding indicates a strong association between the selected position G36D and HAART therapy (p &lt; 0.0001). The isolates that possess these mutations can develop resistance to EFV more rapidly. Nevertheless, more information about the impact of these mutations in salvage therapy with EFV in patients failing HAART must still be obtained.\n   </abstracttext>\n  </abstract>\n  <affiliation>\n   Laboratory of Molecular Virology, Department of Genetics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.\n  </affiliation>\n  <authorlist completeyn=\"Y\">\n   <author validyn=\"Y\">\n    <lastname>\n     Oliveira\n    </lastname>\n    <forename>\n     A C A\n    </forename>\n    <initials>\n     AC\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Martins\n    </lastname>\n    <forename>\n     A N\n    </forename>\n    <initials>\n     AN\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Pires\n    </lastname>\n    <forename>\n     A F N P C\n    </forename>\n    <initials>\n     AF\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Arruda\n    </lastname>\n    <forename>\n     M B\n    </forename>\n    <initials>\n     MB\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Tanuri\n    </lastname>\n    <forename>\n     A\n    </forename>\n    <initials>\n     A\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Pereira\n    </lastname>\n    <forename>\n     H S\n    </forename>\n    <initials>\n     HS\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Brindeiro\n    </lastname>\n    <forename>\n     R M\n    </forename>\n    <initials>\n     RM\n    </initials>\n   </author>\n  </authorlist>\n  <language>\n   eng\n  </language>\n  <databanklist completeyn=\"Y\">\n   <databank>\n    <databankname>\n     GENBANK\n    </databankname>\n    <accessionnumberlist>\n     <accessionnumber>\n      EU682311\n     </accessionnumber>\n     <accessionnumber>\n      EU682312\n     </accessionnumber>\n     <accessionnumber>\n      EU682313\n     </accessionnumber>\n     <accessionnumber>\n      EU682314\n     </accessionnumber>\n     <accessionnumber>\n      EU682315\n     </accessionnumber>\n     <accessionnumber>\n      EU682316\n     </accessionnumber>\n     <accessionnumber>\n      EU682317\n     </accessionnumber>\n     <accessionnumber>\n      EU682318\n     </accessionnumber>\n     <accessionnumber>\n      EU682319\n     </accessionnumber>\n     <accessionnumber>\n      EU682320\n     </accessionnumber>\n     <accessionnumber>\n      EU682321\n     </accessionnumber>\n     <accessionnumber>\n      EU682322\n     </accessionnumber>\n     <accessionnumber>\n      EU682323\n     </accessionnumber>\n     <accessionnumber>\n      EU682324\n     </accessionnumber>\n     <accessionnumber>\n      EU682325\n     </accessionnumber>\n     <accessionnumber>\n      EU682326\n     </accessionnumber>\n     <accessionnumber>\n      EU682327\n     </accessionnumber>\n     <accessionnumber>\n      EU682328\n     </accessionnumber>\n     <accessionnumber>\n      EU682329\n     </accessionnumber>\n     <accessionnumber>\n      EU682330\n     </accessionnumber>\n     <accessionnumber>\n      EU682331\n     </accessionnumber>\n     <accessionnumber>\n      EU682332\n     </accessionnumber>\n     <accessionnumber>\n      EU682333\n     </accessionnumber>\n     <accessionnumber>\n      EU682334\n     </accessionnumber>\n     <accessionnumber>\n      EU682335\n     </accessionnumber>\n     <accessionnumber>\n      EU682336\n     </accessionnumber>\n     <accessionnumber>\n      EU682337\n     </accessionnumber>\n     <accessionnumber>\n      EU682338\n     </accessionnumber>\n     <accessionnumber>\n      EU682339\n     </accessionnumber>\n     <accessionnumber>\n      EU682340\n     </accessionnumber>\n     <accessionnumber>\n      EU682341\n     </accessionnumber>\n     <accessionnumber>\n      EU682342\n     </accessionnumber>\n     <accessionnumber>\n      EU682343\n     </accessionnumber>\n     <accessionnumber>\n      EU682344\n     </accessionnumber>\n     <accessionnumber>\n      EU682345\n     </accessionnumber>\n     <accessionnumber>\n      EU682346\n     </accessionnumber>\n     <accessionnumber>\n      EU682347\n     </accessionnumber>\n     <accessionnumber>\n      EU682348\n     </accessionnumber>\n     <accessionnumber>\n      EU682349\n     </accessionnumber>\n     <accessionnumber>\n      EU682350\n     </accessionnumber>\n     <accessionnumber>\n      EU682351\n     </accessionnumber>\n     <accessionnumber>\n      EU682352\n     </accessionnumber>\n     <accessionnumber>\n      EU682353\n     </accessionnumber>\n     <accessionnumber>\n      EU682354\n     </accessionnumber>\n     <accessionnumber>\n      EU682355\n     </accessionnumber>\n     <accessionnumber>\n      EU682356\n     </accessionnumber>\n     <accessionnumber>\n      EU682357\n     </accessionnumber>\n     <accessionnumber>\n      EU682358\n     </accessionnumber>\n     <accessionnumber>\n      EU682359\n     </accessionnumber>\n     <accessionnumber>\n      EU682360\n     </accessionnumber>\n     <accessionnumber>\n      EU682361\n     </accessionnumber>\n     <accessionnumber>\n      EU682362\n     </accessionnumber>\n     <accessionnumber>\n      EU682363\n     </accessionnumber>\n     <accessionnumber>\n      EU682364\n     </accessionnumber>\n     <accessionnumber>\n      EU682365\n     </accessionnumber>\n     <accessionnumber>\n      EU682366\n     </accessionnumber>\n     <accessionnumber>\n      EU682367\n     </accessionnumber>\n     <accessionnumber>\n      EU682368\n     </accessionnumber>\n     <accessionnumber>\n      EU682369\n     </accessionnumber>\n     <accessionnumber>\n      EU682370\n     </accessionnumber>\n     <accessionnumber>\n      EU682371\n     </accessionnumber>\n     <accessionnumber>\n      EU682372\n     </accessionnumber>\n     <accessionnumber>\n      EU682373\n     </accessionnumber>\n     <accessionnumber>\n      EU682374\n     </accessionnumber>\n     <accessionnumber>\n      EU682375\n     </accessionnumber>\n    </accessionnumberlist>\n   </databank>\n  </databanklist>\n  <publicationtypelist>\n   <publicationtype>\n    Journal Article\n   </publicationtype>\n  </publicationtypelist>\n </article>\n <medlinejournalinfo>\n  <country>\n   United States\n  </country>\n  <medlineta>\n   AIDS Res Hum Retroviruses\n  </medlineta>\n  <nlmuniqueid>\n   8709376\n  </nlmuniqueid>\n  <issnlinking>\n   0889-2229\n  </issnlinking>\n </medlinejournalinfo>\n <chemicallist>\n  <chemical>\n   <registrynumber>\n    0\n   </registrynumber>\n   <nameofsubstance>\n    HIV Envelope Protein gp41\n   </nameofsubstance>\n  </chemical>\n  <chemical>\n   <registrynumber>\n    0\n   </registrynumber>\n   <nameofsubstance>\n    HIV Fusion Inhibitors\n   </nameofsubstance>\n  </chemical>\n  <chemical>\n   <registrynumber>\n    0\n   </registrynumber>\n   <nameofsubstance>\n    Peptide Fragments\n   </nameofsubstance>\n  </chemical>\n  <chemical>\n   <registrynumber>\n    0\n   </registrynumber>\n   <nameofsubstance>\n    enfuvirtide\n   </nameofsubstance>\n  </chemical>\n </chemicallist>\n <citationsubset>\n  IM\n </citationsubset>\n <citationsubset>\n  X\n </citationsubset>\n <meshheadinglist>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Adult\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Amino Acid Sequence\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Amino Acid Substitution\n   </descriptorname>\n   <qualifiername majortopicyn=\"N\">\n    genetics\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"Y\">\n    Antiretroviral Therapy, Highly Active\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Brazil\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"Y\">\n    Drug Resistance, Viral\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Genotype\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    HIV Envelope Protein gp41\n   </descriptorname>\n   <qualifiername majortopicyn=\"N\">\n    genetics\n   </qualifiername>\n   <qualifiername majortopicyn=\"Y\">\n    pharmacology\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    HIV Fusion Inhibitors\n   </descriptorname>\n   <qualifiername majortopicyn=\"Y\">\n    pharmacology\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    HIV Infections\n   </descriptorname>\n   <qualifiername majortopicyn=\"N\">\n    drug therapy\n   </qualifiername>\n   <qualifiername majortopicyn=\"Y\">\n    virology\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    HIV-1\n   </descriptorname>\n   <qualifiername majortopicyn=\"N\">\n    classification\n   </qualifiername>\n   <qualifiername majortopicyn=\"N\">\n    drug effects\n   </qualifiername>\n   <qualifiername majortopicyn=\"Y\">\n    genetics\n   </qualifiername>\n   <qualifiername majortopicyn=\"N\">\n    isolation &amp; purification\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Humans\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Middle Aged\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Molecular Sequence Data\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"Y\">\n    Mutation, Missense\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Peptide Fragments\n   </descriptorname>\n   <qualifiername majortopicyn=\"Y\">\n    pharmacology\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Sequence Alignment\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Sequence Analysis, DNA\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Treatment Failure\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Young Adult\n   </descriptorname>\n  </meshheading>\n </meshheadinglist>\n</medlinecitation>\n<pubmeddata>\n <history>\n  <pubmedpubdate pubstatus=\"entrez\">\n   <year>\n    2009\n   </year>\n   <month>\n    2\n   </month>\n   <day>\n    26\n   </day>\n   <hour>\n    9\n   </hour>\n   <minute>\n    0\n   </minute>\n  </pubmedpubdate>\n  <pubmedpubdate pubstatus=\"pubmed\">\n   <year>\n    2009\n   </year>\n   <month>\n    2\n   </month>\n   <day>\n    26\n   </day>\n   <hour>\n    9\n   </hour>\n   <minute>\n    0\n   </minute>\n  </pubmedpubdate>\n  <pubmedpubdate pubstatus=\"medline\">\n   <year>\n    2009\n   </year>\n   <month>\n    3\n   </month>\n   <day>\n    13\n   </day>\n   <hour>\n    9\n   </hour>\n   <minute>\n    0\n   </minute>\n  </pubmedpubdate>\n </history>\n <publicationstatus>\n  ppublish\n </publicationstatus>\n <articleidlist>\n  <articleid idtype=\"doi\">\n   10.1089/aid.2008.0160\n  </articleid>\n  <articleid idtype=\"pubmed\">\n   19239358\n  </articleid>\n </articleidlist>\n</pubmeddata>\n</pubmedarticle>\n", 
            "PMID": 19239358, 
            "HasMut": false, 
            "PMCID": null
        }
    }, 
    {
        "pk": 6, 
        "model": "Interaction.reference", 
        "fields": {
            "Article": 11520, 
            "Tag": 12, 
            "Mutation": 1180
        }
    }, 
    {
        "pk": 5, 
        "model": "Interaction.reference", 
        "fields": {
            "Article": 11520, 
            "Tag": 4, 
            "Mutation": 1180
        }
    }, 
    {
        "pk": 4, 
        "model": "Interaction.reference", 
        "fields": {
            "Article": 11520, 
            "Tag": 1, 
            "Mutation": 1180
        }
    }, 
    {
        "pk": 3, 
        "model": "Interaction.reference", 
        "fields": {
            "Article": 15716, 
            "Tag": 3, 
            "Mutation": 1177
        }
    }, 
    {
        "pk": 2, 
        "model": "Interaction.reference", 
        "fields": {
            "Article": 10277, 
            "Tag": 12, 
            "Mutation": 1055
        }
    }, 
    {
        "pk": 1, 
        "model": "Interaction.reference", 
        "fields": {
            "Article": 10277, 
            "Tag": 1, 
            "Mutation": 1055
        }
    }
]
